Australia markets closed

G Medical Innovations Holdings Ltd (GMVDF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0080-0.0010 (-11.11%)
At close: 03:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 267.82k
Enterprise value 2.06M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)N/A
Enterprise value/revenue 0.47
Enterprise value/EBITDA -0.31

Trading information

Stock price history

Beta (5Y monthly) -1.15
52-week change 3-97.66%
S&P500 52-week change 324.96%
52-week high 30.3940
52-week low 30.0030
50-day moving average 30.0124
200-day moving average 30.0221

Share statistics

Avg vol (3-month) 365.28k
Avg vol (10-day) 385.52k
Shares outstanding 5259.92M
Implied shares outstanding 6259.92M
Float 84.96M
% held by insiders 157.78%
% held by institutions 10.25%
Shares short (31 July 2023) 468.79k
Short ratio (31 July 2023) 40.31
Short % of float (31 July 2023) 40.89%
Short % of shares outstanding (31 July 2023) 40.70%
Shares short (prior month 30 June 2023) 497.1k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:35
Last split date 321 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-301.50%

Management effectiveness

Return on assets (ttm)-223.32%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)4.42M
Revenue per share (ttm)6.13
Quarterly revenue growth (yoy)7.90%
Gross profit (ttm)N/A
EBITDA -26.65M
Net income avi to common (ttm)-13.52M
Diluted EPS (ttm)-18.7600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)295k
Total cash per share (mrq)0.04
Total debt (mrq)2.09M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.22
Book value per share (mrq)-4.82

Cash flow statement

Operating cash flow (ttm)-18.48M
Levered free cash flow (ttm)-4.87M